[Confidence Level: High] Cimeio Therapeutics is a Swiss-based therapeutics organization developing Shielded-Cell & Immunotherapy Pairs™ (SCIP), a proprietary platform designed to transform the treatment of hematologic diseases by genetically shielding healthy hematopoietic stem cells (HSCs) from targeted immunotherapies.1
[Confidence Level: High] Cimeio Therapeutics is a Swiss-based therapeutics organization developing Shielded-Cell & Immunotherapy Pairs™ (SCIP), a proprietary platform designed to transform the treatment of hematologic diseases by genetically shielding healthy hematopoietic stem cells (HSCs) from targeted immunotherapies.1
This is an extract of the full organization profile. To access the full company profile, .
Desktop only
The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.